Search Results

Cost-effectiveness analysis of a new paradigm to simplify testing, monitoring and treatment of hepatitis C virus in the United States.

• Authors : Dietrich, Douglas¹ (AUTHOR); Reau, Nancy² (AUTHOR); Ahmed, Aijaz³ (AUTHOR)

• Source: Cost Effectiveness & Resource Allocation. 6/4/2025, Vol. 23 Issue 1, p1-8. 8p.

Record details

Age-period-cohort and bayesian age-period-cohort prediction modeling of hepatitis C incidence and mortality in China.

• Authors : Lin, Fei¹ (AUTHOR); Liu, Zhenzhou¹ (AUTHOR); Zhai, Jianli¹ (AUTHOR)

Subjects: *Hepatitis C; *Global burden of disease; *Medical sciences

• Source: BMC Public Health. 6/4/2025, Vol. 25 Issue 1, p1-13. 13p.

Record details

Impact of hepatitis C virus genotype on the efficacy of the direct-acting antivirals in chronic kidney disease patients in West Bengal, India.

• Authors : Bakshi, Sagnik¹ (AUTHOR) ; Dutta, Supradip¹ (AUTHOR) ; Biswas, Aritra¹ (AUTHOR)

• Source: BMC Infectious Diseases. 5/16/2025, Vol. 25 Issue 1, p1-12. 12p.

Record details

Prediction of hepatitis-C virus using statistical learning models.

• Authors : Kumari, Shalini¹ (AUTHOR); Das, Subhajit² (AUTHOR); Sonker, Prashant Kumar³ (AUTHOR)

• Source: Discover Public Health. 5/27/2025, Vol. 22 Issue 1, p1-16. 16p.

Record details

Prevalence-based screening by anti-HCV reflex HCV antigen test and accessible post-screening care towards elimination of hepatitis C in rural villages.

• Authors : Pan, Kuan-Chen¹ (AUTHOR); Hsu, Nien-Tzu² (AUTHOR); Tang, Ying-Mei¹ (AUTHOR)

• Source: BMC Gastroenterology. 5/23/2025, Vol. 25 Issue 1, p1-9. 9p.

Record details

The interplay of socio-demographic factors and disease prevalence: insights into malaria, Hepatitis B, and Hepatitis C in Lafia, Nasarawa State, Nigeria.

• Authors : Aremu, Dorcas Oluwakemi^1,2 (AUTHOR) ; Maxim, Antipov¹ (AUTHOR); Aremu, Stephen Olaide³ (AUTHOR)

Subjects: *Malaria; *Disease prevalence; *Hepatitis BNigeria

• Source: Journal of Health, Population & Nutrition. 3/6/2025, Vol. 44 Issue 1, p1-21. 21p.

Record details

Prevalence of HIV and Hepatitis C and access to opioid substitution treatment among people who inject drugs in three cities in Croatia: findings from the second wave of respondent-driven sampling surveys.

• Authors : Šević, Sandra¹ (AUTHOR); Koletić, Goran¹ (AUTHOR); Blažić, Tatjana Nemeth² (AUTHOR)

• Source: Harm Reduction Journal. 3/5/2025, Vol. 22 Issue 1, p1-11. 11p.

Record details

Engagement in hepatitis C virus cascade of care and factors associated with testing among people who inject drugs in Iran.

• Authors : Khezri, Mehrdad^1,2 (AUTHOR); Tavakoli, Fatemeh² (AUTHOR); Mehmandoost, Soheil² (AUTHOR)

• Source: Harm Reduction Journal. 4/8/2025, Vol. 22 Issue 1, p1-10. 10p.

Record details

Epidemiological trends of hepatitis C incidence and death in Mainland China between 2004 and 2018 and its predictions to 2030.

• Authors : Tian, Guo¹ (AUTHOR) ; Zheng, Yang¹ (AUTHOR) ; He, Yinghua^2,3 (AUTHOR)

• Source: BMC Infectious Diseases. 4/8/2025, Vol. 25 Issue 1, p1-10. 10p.

Record details

Integrative analysis of serum proteomics and transcriptomics in hepatitis C.

• Authors : Wang, Jianqiong¹ (AUTHOR) ; Xia, Andong² (AUTHOR) ; Tang, Min¹ (AUTHOR)

• Source: Virology Journal. 3/13/2025, Vol. 22 Issue 1, p1-16. 16p.

Record details